GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaSGP Holding SE (XTER:PSG) » Definitions » 3-Year Revenue Growth Rate

PharmaSGP Holding SE (XTER:PSG) 3-Year Revenue Growth Rate : 16.90% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is PharmaSGP Holding SE 3-Year Revenue Growth Rate?

PharmaSGP Holding SE's Revenue per Share for the three months ended in Sep. 2024 was €2.53.

During the past 12 months, PharmaSGP Holding SE's average Revenue per Share Growth Rate was 17.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 16.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 5 years, the highest 3-Year average Revenue per Share Growth Rate of PharmaSGP Holding SE was 16.90% per year. The lowest was 11.10% per year. And the median was 14.00% per year.


Competitive Comparison of PharmaSGP Holding SE's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaSGP Holding SE's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaSGP Holding SE's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaSGP Holding SE's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where PharmaSGP Holding SE's 3-Year Revenue Growth Rate falls into.


;
;

PharmaSGP Holding SE 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


PharmaSGP Holding SE  (XTER:PSG) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


PharmaSGP Holding SE 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of PharmaSGP Holding SE's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaSGP Holding SE Business Description

Traded in Other Exchanges
Address
Lochhamer Schlag 1, Graefelfing, Munich, DEU, 82166
PharmaSGP Holding SE is a pharmaceutical company. The company develops chemical-free, over-the-counter (OTC) drugs and healthcare products. The product portfolio includes RUBAXX for rheumatic pain Restaxil for nerve pain, and Deseo for sexual dysfunction. It has established various consumer brands in important indication areas, such as rheumatic and neuralgic pain or sexual weakness Also, the company offers products for skin aging and vertigo.
Executives
Dr. Clemens Fischer Supervisory Board
Madlena Hohlefelder Supervisory Board

PharmaSGP Holding SE Headlines

No Headlines